Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne I J Arens

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Kidney Medicine|August 1, 2020
A Wandering KidneyC R Susanto, Anne I J Arens
Clinical Nuclear Medicine|March 6, 2015
Anakinra injection site reaction on FDG PET/CTAnne I J Arens, Dennis Vriens, Marijn Janssen, et al.
Ejhaem|December 14, 2021
Axillary lymph nodes on PET in Hodgkin lymphoma after COVID-19 vaccinationAnne I J Arens, Konnie M Hebeda, Martin Hutchings, et al.
Clinical Nuclear Medicine|August 29, 2018
68Ga-PSMA Uptake in AngiolipomaIrma Dekker, Marloes van der Leest, Maartje C van Rijk, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 2, 2012
FDG-PET/CT based response-adapted treatmentLioe-Fee de Geus-Oei, Dennis Vriens, Anne I J Arens, et al.
Clinical Nuclear Medicine|October 8, 2020
Humongous Seminal Vesicles on 68Ga-DOTATOC PET/CT: A Rare Presentation of a Neuroendocrine TumorRomee A Hendriks, Stefan P Hoogendoorn, Willemijn A M van Gemert, et al.
Clinical Nuclear Medicine|April 6, 2012
False positive 18F-FDG PET/CT due to inflamed concha bullosaAnne I J Arens, Berit M Verbist, Baudewijn W Hendrickx, et al.
Nuclear Medicine Communications|November 2, 2013
The influence of SPECT reconstruction algorithms on image quality and diagnostic accuracy in phantom measurements and 99mTc-sestamibi parathyroid scintigraphyRalph A van Hoorn, Dennis Vriens, Jan-Willem A Postema, et al.
Clinical Nuclear Medicine|May 19, 2010
Hardware failure: a potential pitfall in assessing recurrent Ewing's sarcoma on bone scintigraphyDennis Vriens, Anne I J Arens, Jacky W J de Rooy, et al.
EJNMMI Research|October 25, 2023
Quantitative and clinical implications of the EARL2 versus EARL1 [<sup>18</sup>F]FDG PET-CT performance standards in head and neck squamous cell carcinomaMaurice C Cox, Tijn Jurcka, Anne I J Arens, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Kidney Medicine|August 1, 2020
A Wandering KidneyC R Susanto, Anne I J Arens
Clinical Nuclear Medicine|March 6, 2015
Anakinra injection site reaction on FDG PET/CTAnne I J Arens, Dennis Vriens, Marijn Janssen, et al.
Ejhaem|December 14, 2021
Axillary lymph nodes on PET in Hodgkin lymphoma after COVID-19 vaccinationAnne I J Arens, Konnie M Hebeda, Martin Hutchings, et al.
Clinical Nuclear Medicine|August 29, 2018
68Ga-PSMA Uptake in AngiolipomaIrma Dekker, Marloes van der Leest, Maartje C van Rijk, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 2, 2012
FDG-PET/CT based response-adapted treatmentLioe-Fee de Geus-Oei, Dennis Vriens, Anne I J Arens, et al.
Clinical Nuclear Medicine|October 8, 2020
Humongous Seminal Vesicles on 68Ga-DOTATOC PET/CT: A Rare Presentation of a Neuroendocrine TumorRomee A Hendriks, Stefan P Hoogendoorn, Willemijn A M van Gemert, et al.
Clinical Nuclear Medicine|April 6, 2012
False positive 18F-FDG PET/CT due to inflamed concha bullosaAnne I J Arens, Berit M Verbist, Baudewijn W Hendrickx, et al.
Nuclear Medicine Communications|November 2, 2013
The influence of SPECT reconstruction algorithms on image quality and diagnostic accuracy in phantom measurements and 99mTc-sestamibi parathyroid scintigraphyRalph A van Hoorn, Dennis Vriens, Jan-Willem A Postema, et al.
Clinical Nuclear Medicine|May 19, 2010
Hardware failure: a potential pitfall in assessing recurrent Ewing's sarcoma on bone scintigraphyDennis Vriens, Anne I J Arens, Jacky W J de Rooy, et al.
EJNMMI Research|October 25, 2023
Quantitative and clinical implications of the EARL2 versus EARL1 [<sup>18</sup>F]FDG PET-CT performance standards in head and neck squamous cell carcinomaMaurice C Cox, Tijn Jurcka, Anne I J Arens, et al.
Pageof 4